Company / Revenue
Nuo Therapeutics, Inc. Revenue History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$721.0K
FY2017
5-year range
$472.4K / $11.6M
FY2013-FY2017
Trend
+52.6%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 7 years, ranging from $472,445 in FY2016 to $12M in FY2013.
Based on SEC 10-K filings.
$721,045 in FY2017 with a 5-year CAGR of -41.5%.
Declined from $12M to $721,045 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -54.7%
- 5-Year CAGR
- -41.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -41.5%, indicating a declining trend.
- In FY2017, revenue increased 52.6% year-over-year.
- Peak revenue was recorded in FY2013.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $721.0K | +52.6% |
| FY2016 | $472.4K | -95.9% |
| FY2015 | $11.5M | +48.3% |
| FY2014 | $7.8M | -32.9% |
| FY2013 | $11.6M | +9.5% |
| FY2012 | $10.6M | +45.8% |
| FY2011 | $7.2M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026